| Record 3520 View: Standard | Glossary HistCite Guide |
|
Author(s): Maranghi F (Maranghi, Francesca); Tassinari R (Tassinari, Roberta); Marcoccia D (Marcoccia, Daniele); Altieri I (Altieri, Ilaria); Catone T (Catone, Tiziana); De Angelis G (De Angelis, Giovanna); Testai E (Testai, Emanuela); Mastrangelo S (Mastrangelo, Sabina); Evandri MG (Evandri, Maria Grazia); Bolle P (Bolle, Paola); Lorenzetti S (Lorenzetti, Stefano)
Title: The food contaminant semicarbazide acts as an endocrine disrupter: Evidence from an integrated in vivo/in vitro approach
Source: CHEMICO-BIOLOGICAL INTERACTIONS 183 (1): 40-48
Date: 2010 JAN 5
Document Type: Journal : Article
DOI: 10.1016/j.cbi.2009.09.016
Language: English
Comment:
Address: Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy.
Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy. Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, I-00185 Rome, Italy. Reprint: Maranghi, F, Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale
Regina Elena 299, I-00161 Rome, Italy. E-mail: francesca.maranghi@iss.it
roberta.tassinari@iss.it daniele430@alice.it ilaria.altieri@iss.it tiziana.catone@iss.it giovanna.deangelis@iss.it emanuela.testai@iss.it sabina.mastrangelo@uniroma1.it mariagrazia.evandri@uniroma1.it paola.bolle@uniroma1.it stefano.lorenzetti@iss.it Author Keywords: Semicarbazide; Food contaminant; Endocrine disrupters; Sex steroids;
Estrogen receptor alpha; N-methyl-D-aspartate receptor
KeyWords Plus: NMDA RECEPTOR SUBUNITS; SEXUAL DEVELOPMENT; STEROID-HORMONES; AMINE
OXIDASES; FEMALE RATS; BABY FOOD; METABOLISM; EXPRESSION; PRODUCTS;
AZODICARBONAMIDE
Abstract: Semicarbazide (SEM) is a by-product of the blowing agent azodicarbonamide, present in glass jar-sealed foodstuffs mainly baby foods. The pleiotropic in vivo SEM toxicological effects suggested to explore its possible role as endocrine modulator. Endocrine effects of SEM were assessed in vivo in male and female rats after oral administration for 28 days at 0, 40, 75, 140 mg/kg bw pro die during the juvenile period. Vaginal opening and preputial separation were recorded. Concentration of sex steroid in blood, the ex vivo hepatic aromatase activity and testosterone catabolism were detected. The in vitro approach to test SEM role as (anti)estrogen or N-methyl-D-aspartate receptors (NMDARs)-(anti)agonist included different assays: yeast estrogenicity. MCF-7 proliferation, stimulation of the alkaline phosphatase activity in Ishikawa cells and LNCaP-based NMDAR interference assay. In vivo SEM-treated female rats showed delayed vaginal opening at all tested doses, whereas in males preputial separation was anticipated at SEM 40 and 75 mg/kg and delayed at 140 mg/kg, the latter effect probably due to the significantly decreased body weight gain seen at the higher dose in both sexes. Serum estrogen levels were dose-dependently reduced in treated females, whereas dehydrotestosterone serum levels were also decreased but a clear dose-response was not evidenced. Testosterone catabolism was altered in a gender-related way, aromatase activity was increased in treated males at 75 and 140 mg/kg and in females in all dose groups. In the three estradiol-competitive assays, SEM showed a weak anti-estrogenic activity, whereas in the LNCaP-based NMDAR interference assay SEM activity resembled MK-801 antagonist effect. SEM appeared to act as an endocrine disrupter showing multiple and gender specific mechanisms of action(s). A possible cascade-mechanism of SEM on reproductive signalling pathways may be hypothesized. Such in vivo-in vitro approach appeared to be an useful tool to highlight SEM activity on endocrine homeostasis. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
Cited References: 2004, OFFICIAL J EUROPEAN BENDALL JG, 2008, FOOD ADDIT CONTAM, V12, P1 BENEDETTI MS, 2007, FUND CLIN PHARMACOL, V21, P467, DOI 10.1111/j.1472-8206.2007.00498.x BOURGUIGNON JP, 1992, J CLIN INVEST, V90, P1736 BRENT RL, 2004, BIRTH DEFECTS RES B, V71, P303, DOI 10.1002/bdrb.20020 CHAKRABORTY TR, 2003, ENDOCRINOLOGY, V144, P299, DOI 10.1210/en.2002-220749 CHRISTIAN CA, 2009, BIOL REPROD, V80, P1128, DOI 10.1095/biolreprod.108.075077 CREWS D, 2000, Q REV BIOL, V75, P243 FRANKLIN IK, 2004, J GEN PHYSIOL, V123, P185, DOI 10.1085/jgp.200409016 GATERMANN R, 2004, CZECH J FOOD SCI, V22, P353 GONG B, 2006, EXPERT OPIN DRUG MET, V2, P559 GONZALEZCADAVID NF, 2000, J ANDROL, V21, P566 GORE AC, 2001, BRAIN RES REV, V37, P235 GROTE K, 2006, TOXICOLOGY, V222, P17, DOI 10.1016/j.tox.2006.01.008 KINEMUCHI H, 2004, NEUROTOXICOLOGY, V25, P325, DOI 10.1016/S0161-813X(03)00118-9 LEHMANN L, 2005, TOXICOL LETT, V158, P72, DOI 10.1016/j.toxlet.2005.02.011 MAFFUCCI JA, 2008, NEUROENDOCRINOLOGY, V87, P129, DOI 10.1159/000111136 MANTOVANI A, 2002, TOXICOLOGY IN PRESS, V27, P367 MARANGHI F, 2009, FOOD CHEM TOXICOL, V47, P472, DOI 10.1016/j.fct.2008.12.003 MOGUILEVSKY JA, 2001, EXP CLIN ENDOCR DIAB, V109, P188 MULDER PPJ, 2007, ANAL CHIM ACTA, V586, P366, DOI 10.1016/j.aca.2006.11.033 NESTMANN ER, 2005, FOOD ADDIT CONTAM, V22, P875, DOI 10.1080/02652030500195312 NOONAN GO, 2008, J AGR FOOD CHEM, V26, P2064 OYAMA VI, 1956, P SOC EXP BIOL MED, V91, P305 PAOLETTI P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011 ROUTLEDGE EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241 SAARINEN NM, 2006, GENES NUTR, V1, P143 SANTOS JM, 2008, NEUROBIOL LEARN MEM, V90, P560, DOI 10.1016/j.nlm.2008.06.007 SANWALD P, 1995, J CHROMATOGR B, V672, P207 SZILAGYI S, 2006, EUR FOOD RES TECHNOL, V224, P141, DOI 10.1007/s00217-006-0296-y TESTAI E, 1986, CHEM-BIOL INTERACT, V59, P157 WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71 YE L, 2009, MOL CELL ENDOCRINOL, V302, P73, DOI 10.1016/j.mce.2009.01.003 YIN W, 2007, EXP BIOL MED, V232, P662 YOU L, 2001, MOL CELL ENDOCRINOL, V178, P207 |